Related Experiment Videos
[Pathogenetic mechanisms of chronicity in liver diseases in patients with circulatory failure]
Insights
Chronic heart failure (CHF) can cause liver diseases that mimic other conditions. Identifying specific liver disease markers helps differentiate these from primary liver issues in CHF patients.
Area of Science:
- Hepatology
- Cardiology
- Internal Medicine
Background:
- Chronic heart failure (CHF) frequently leads to liver conditions, often presenting atypically with a chronic course.
- CHF is a key factor in the chronicity of co-occurring liver diseases, potentially masking primary liver pathology.
- Persistent hepatomegaly and refractory CHF warrant investigation for independent liver diseases.
Purpose of the Study:
- To elucidate the role of chronic heart failure in the pathogenesis and chronicity of liver diseases.
- To highlight the diagnostic challenges posed by liver conditions in CHF patients.
- To identify biochemical markers for differentiating CHF-related liver issues from independent liver diseases.
Main Methods:
- Review of clinical presentations and pathogenetic mechanisms of liver diseases in CHF.
- Analysis of hemodynamic indices and hepatomegaly in relation to CHF severity.
- Evaluation of enzymatic markers (haptoglobin, ceruloplasmin, glutamic acid dehydrogenase) for liver damage and fibrosis.
Main Results:
- CHF significantly contributes to the chronicity and fibrosing reaction of liver diseases.
- Atypical presentations are common, complicating diagnosis.
- Enzymatic markers reflect damage to the liver's endoplasmic reticulum and can aid differential diagnosis.
Conclusions:
- CHF is a critical factor in the chronicity of associated liver diseases.
- Enzymatic markers like haptoglobin, ceruloplasmin, and glutamic acid dehydrogenase are valuable for distinguishing between cardiovascular-induced liver disorders and independent liver diseases.
- Physicians should consider independent liver diseases when CHF and hepatomegaly are refractory or hemodynamic indices are inconsistent.
Abstract:
Patients with chronic heart failure (CHF) can often develop such diseases as hepatitis of viral etiology, alcoholic hepatitis, drug affection of the liver and other diseases masked as congestive liver. In most cases CHF concomitant liver diseases have an atypical course with a tendency to a chronic course. CHF is one of the important pathogenetic mechanisms lying in the basis of chronicity of concomitant liver diseases. Refractory CHF, inconsistency of the hemodynamic indices of persistent hepatomegaly must lead a physician to the detection of probable independent liver diseases complicating the syndrome of heart failure. CHF is a factor causing an enhanced fibrosing liver reaction. An important diagnostic test of fibrinogenesis lying in the basis of chronicity of liver diseases, is the determination of enzymatic markers reflecting synthesis and catabolism of the main substance of connective tissue. Change in the levels of haptoglobin, ceruloplasmin and glutamic acid dehydrogenase is an indirect sign of damage of the liver parenchymal endoplasmic reticulum. These indices can serve as differential criteria of the prevalence of cardiovascular disorders in the liver or concomitant independent liver diseases.